QUIN
LIVE

Serial Number

79424278

Owner

Quin B.V.

Filing Date

Apr 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

QUIN Trademark

Serial Number: 79424278

QUIN is a trademark filed by Quin B.V. on April 14, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Quin B.V. (2 trademarks)

Stadhouderskade 55

Entity Type: 78

Trademark Details

Filing Date

April 14, 2025

Registration Date

Not Registered

Goods & Services

IT services; development, programming, implementation, provision and maintenance of software, also for platforms, software applications, mobile applications, web applications and portals; platforms for artificial intelligence as software as a service (SaaS); hosting services and providing software (SaaS) and rental of software, in particular for medical applications; platform as a service (PaaS); hosting a platform with pharmaceutical and medical information as well as health management information; information technology services for the pharmaceutical and healthcare industries; design and development of software for use with medical technology; providing non-downloadable software, including via a platform, for obtaining, registering, managing, checking and analyzing medical information and medical (research) data, including that of patients; providing non-downloadable software, including through a platform, for determining triage, diagnoses, prognoses and treatment processes of patients; providing non-downloadable software, including through a platform, to facilitate health management and self-care to consumers and patients; medical and pharmaceutical research services; computer programming for medical applications; electronic storage of medical records; leasing of computer hardware and software for medical imaging; advice and information in relation to the aforementioned services; all the aforesaid services focused on medical and pharmaceutical matters.

Healthcare for people; medical services; providing information, advice and data on medical imaging; providing medical information, advice and data, including through a platform, on health management and self-care, including to consumers and patients; medical health assessments; medical consultation; performing diagnostics for diseases (also through artificial intelligence software); health risk assessment studies; medical advice whether or not provided on the basis of predictive (artificial intelligence) software; providing medical information, treatment plans and medical diagnoses and prognoses; medical analysis for the diagnosis, prognosis and treatment of persons; medical analysis, diagnosis, prognosis and treatment processes based on self-learning and artificial intelligence software; providing information to patients in the field of drug administration; all the aforesaid services also provided electronically, such as via the Internet.

Self-learning and artificial intelligence software for healthcare; health monitoring software; downloadable software and application software for mobile phones and other digital devices for obtaining, registering, managing, checking and analyzing medical information and medical (research) data; downloadable software and application software for mobile telephones and other digital devices for determining triage, diagnoses, prognoses and treatment processes of patients, the aforementioned software also to be used in combination with GP information systems (HIS); mobile applications; all the aforementioned products in the medical and pharmaceutical fields.

Filing History

REFUSAL PROCESSED BY IB
Mar 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 3, 2026 RFCS
REFUSAL PROCESSED BY MPU
Mar 3, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 4, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 3, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 26, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 25, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 22, 2025 REPR